Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velzatinib vs Imatinib in Previously Untreated GIST
NCT07585266Phase 3Recruiting
- Sponsor
- GSK
- Start
- Jul 2026
- Primary completion
- Aug 2032
- Countries
- 20
01
Overview
A Phase 3 trial of velzatinib in gastrointestinal stromal tumor (GIST), sponsored by GSK. Started Jul 2026; status: recruiting.
02
Drugs
velzatinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT07585266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07585266.